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44788 | RSC Adv., 2017, 7, 44788–4479w mesoporous hydroxyapatite
microsphere with controlled morphology,
entrapment eﬃciency and degradability for cancer
therapy
Wei Qiao, †ac Xinmiao Lan, †b James K. H. Tsoi, a Zhuofan Chen,d
Richard Y. X. Su,*b Kelvin W. K. Yeung*c and Jukka P. Matinlinna*a
Hollow hydroxyapatite (HAp) microspheres bearing hierarchical structures have been one of the most
popular carriers for drug delivery. However, it's been challenging to ﬁnd an approach that can
simultaneously control the morphology, degradability and drug loading/releasing properties of the
microsphere. In this study, hollow mesoporous microspheres composed of nano-sized HAp crystals
were hydrothermally synthesized from hollow CaCO3 precursors prepared via sodium dodecyl sulfate
(SDS)-assisted precipitation. The particle size, hollow structure and wall thickness of the fabricated
hollow mesoporous carbonated HAp microsphere (CHAM) could be facilely regulated by tailoring the
concentration of SDS in the reaction. The achieved carbonate-containing CHAMs were demonstrated to
be suitable for drug delivery through either surface attachment or intracellular engulfment without
causing cytotoxicity. In addition, their distinguished biodegradability and sustained drug release
properties in a pH-dependent manner might allow them to be used in cancer treatment by targeting the
acidic microenvironment in a solid tumor. Moreover, the CHAM prepared using SDS at its critical micelle
concentration (CMC) was suggested to be optimal for anti-cancer therapy due to its highest entrapment
eﬃciency of cis-diammineplatinum(II) dichloride (CDDP) and the strongest killing eﬀect on human
squamous cell carcinoma in vitro.1. Introduction
Hydroxyapatite (HAp) microspheres are among the most
extensively studied carriers for the delivery of drugs, proteins
and genes. As the major inorganic component of human hard
tissues (e.g. bones and teeth), the biocompatibility and biode-
gradability of HAp microsphere are superior to many other
hybrid microspheres.1–3 Moreover, the facile modication ofnces, Faculty of Dentistry, The University
ntal Hospital, 34 Hospital Road, Sai Ying
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ly to this study.
8HAp microspheres with relatively low cost and high eﬃciency
allows them to be very versatile for diﬀerent medical applica-
tions. In recent years, a number of studies have been focusing
on optimizing the drug release prole of HAp based delivery
systems through the control of particle size at the nanoscale,4,5
the addition of hierarchical structures6–9 or the modication of
organic components.10,11 Hollow HAp microsphere bearing
mesoporous structure is one of the most popular design among
the drug delivery system, due to its high specic surface area,
low density, high drug loading eﬃciency, and controlled
releasing kinetic.12–15 It was reported that hollow mesoporous
microsphere built by hydroxyapatite nanobers displayed
higher drug loading capacity and a controlled pH-responsive
drug release prole, which is able to kill cancer cells with less
damage to normal cells.16 Indeed, the distinguished properties
of hollow HAp microsphere have allow it to be used for the
delivery of antibiotics,6,17–19 anticancer drugs13 or cytokines20,21
in various applications.
There have been a number of methods reported for the
fabrication of hollow HAp microsphere, including the template
assisted hydrothermal reaction,15,16,22 spray freezing and
drying,23,24 ice-template spray freezing,19,25 microwave assisted
transformation,26 etc. In order to achieve the hollow space in theThis journal is © The Royal Society of Chemistry 2017
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View Article OnlineHAp microspheres, a core template that can be sacriced
following the formation of HAp shell, or a hollow shaped
precursor that can be directly transformed into HAp is needed.
Although a variety of reagents (e.g., poly(aspartic acid),27 hex-
adecyl trimethylammonium bromide (CTAB),22 Deoxy-
ribonucleic acid (DNA)15 block copolymer,28 and sodium
dodecyl sulfate (SDS)6,26) have been known be able to produce
hollow structures in the HAp microsphere, reports on the
regulation of the hollow size and wall thickness are still lacking.
The size of microsphere decides its loading capacity and target
location, while the wall thickness and degradability of the
microsphere are closely related to the release prole of the
loaded drugs. Therefore, it's both vital and challenging to
develop HAp microsphere with controlled morphology,
degradability and drug loading/releasing properties based on
their specic usage.
Sodium dodecyl sulfate, SDS is a synthetic organic
compound with the formula CH3(CH2)11SO4Na. Its amphiphilic
properties, as well as low cytotoxicity or carcinogenicity, allow it
to be widely used in the production of detergents, cosmetic,
medicine and food.29 It was used, together with poly-
vinylpyrrolidone (PVP), to achieve hollow CaCO3 microspheres
via a precipitation reaction at a relatively low concentration.30
However, in some recent studies, the concentration of SDS used
in the preparation of hollow HAp microspheres could be up to
0.1 M (28.8 mg mL1),6,12,26 which is much higher than its crit-
ical concentration to cause cytotoxicity.31 Evenmultiple washing
and rinsing steps have been claimed in the SDS assisted
synthesis, considering the sustained release prole of the
hollow microspheres, there still remains some concerns about
the side eﬀects that might be caused by the residual SDS.
Moreover, even though SDS is among one of the most frequently
used anionic surfactant for the synthesis of hollow structure in
HAp microspheres, investigations on the eﬀects of its concen-
tration on the morphology of microspheres are extremely
limited. It has been known for long that SDS micelles can be
formed at its critical micelle concentration (CMC)32 (i.e. 8.2 mM
in pure water at 25 C (ref. 33)), and grow with the increase in
the concentration of surfactant.34 This implies that the size and
morphology of the hollowHApmicrospheres or their precursors
might be controlled by the concentration of SDS used in the
synthesis.
Therefore, in the present study, diﬀerent concentrations of
SDS were used in fast precipitation for the preparation of hollow
CaCO3 precursors with a diﬀerent particle size, hollow structure
and wall thickness. The precursors were then directly trans-
formed into hollow mesoporous microspheres composed of
nano-sized carbonated hydroxyapatite crystals through hydro-
thermal reaction. The morphology, chemical composition,
phrase purity, size distribution, porosity and degradability of
the samples were systematically characterized for fully eluci-
dating the eﬀects of SDS concentration on the microspheres. In
addition, the microspheres were loaded with cis-dia-
mmineplatinum(II) dichloride (CDDP) for evaluating drug
loading eﬃciency and releasing properties in diﬀerent pH
environment. The biocompatibility of the microspheres and the
cytotoxicity of the CDDP loaded microspheres were tested inThis journal is © The Royal Society of Chemistry 2017vitro using a human squamous cell carcinoma cell line. The
extracellular attachment of the microspheres was observed
under scanning electron microscopy, while the intracellular
engulfment of the rhodamine B isothiocyanate (RITC) conju-
gated microspheres was visualized using confocal microscopy.
The aim of this study was to provide a straight-forward
approach to achieve hollow mesoporous carbonated HAp
microsphere (CHAM) with controlled size, loading capability
and degradability for sustained drug delivery, and to test their
potential applications as drug carriers targeting cancer cells in
vitro.2. Experimental section
2.1. Preparation of HAp microspheres
Hollow mesoporous CaCO3 precursors were prepared by fast
precipitation using sodium dodecyl sulfate (SDS, Sigma Aldrich,
USA) as the surfactant. In brief, 250 mL 0.2 M CaCl2 (AnalaR
grade, BDH, Poole, UK) was mixed with an equal volume of SDS
at diﬀerent concentrations (i.e. 1 mg mL1, 2.33 mg mL1,
4.66 mg mL1, and 10 mg mL1) under vigorous stirring. Then
same volume of 0.2 M Na2CO3$10H2O (AnalaR grade, BDH) was
added to the solution and stirred for 1.5 h. The achieved CaCO3
templates were obtained by ltering oﬀ the liquid with
a vacuum pump. Then, the samples were rinsed eight times
with distilled water and two times with ethanol before being
dried in an oven at 120 C overnight.
The dried CaCO3 precursors were mixed with 0.2 M Na2HPO4
(AnalaR grade, BDH), and drop-wisely added with 0.2 M
ammonia (AnalaR grade, BDH) until the pH value reached 11.
Then the solution was transferred into a Teon-lined stainless
steel autoclave for a hydrothermal reaction at 180 C for 24 h.
The resulting solids were collected by centrifugation, thor-
oughly rinsed with distilled water and ethanol, and then dried
at 120 C for 24 h. According to the concentration of SDS used in
the precursor preparation, the as-prepared samples were noted
as A-CHAM (1 mg mL1 SDS), B-CHAM (2.33 mg mL1 SDS), C-
CHAM (4.66 mg mL1 SDS) and D-CHAM (10 mg mL1 SDS),
respectively. All of the samples were separately stored in
a vacuum desiccator over silica gel before further testing. The
schematic diagram for sample preparation were illustrated in
Fig. 1.2.2. Sample characterization
The morphology of the four groups of CHAMs were observed
under transmission electron microscopy (TEM, CM100, Philips
Electron Optics, The Netherlands) and scanning electron
microscopy (SEM, S-4800, Hitachi, Tokyo, Japan). For TEM
observation, images were taken in the bright eld mode at an
accelerating voltage of 100 kV, and the selected area electron
diﬀraction (SAED) patterns were captured for each sample. The
SEM images of the CHAMs and the crystals were captured at 5
kV, with the elemental composition and distribution examined
by energy-dispersive X-ray spectroscopy (EDX) and SEM-EDX
mapping. The functional groups of CHAMs were identied
using Fourier-transform infrared spectroscopy (FTIR, Vector 33,RSC Adv., 2017, 7, 44788–44798 | 44789
Fig. 1 Schematic diagram showing the synthesis of CHAMs, as well as the drug loading and ﬂuorescent labeling process.
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View Article OnlineBruker Optics, Ettlingen, Germany). IR spectra were collected in
the transmittance mode with a scanning range of 4000–
400 cm1 at a 0.2 cm1 resolution. Phrase analysis of CHAMs
was done by using X-ray diﬀractometer (XRD, Empyrean, Pan-
alytical, Eindhoven, The Netherlands). A scanning speed of 10
(2q)/min and a step size of 0.01 were adopted over a 2q range of
20–60. A stoichiometric HAp pattern (JCPDS card #09-0432)
were used as references for peak tting in Jade soware (v. 6.1,
Materials Data, Livermore, California, USA). The particle size
and the zeta potential of CHAMs were determined by dispersing
the samples in 1 mM KCl solution, and measured by a dynamic
light scattering particle analyzer (Nanotrac Wave II, Microtract,
FL, USA). The Brunauer–Emmett–Teller (BET) specic surface
area and the Barrett–Joyner–Halenda (BJH) pore-size distribu-
tion were recorded using a Quantachrome QuadraSorb SI
instrument (Quantachrome, USA).2.3. Degradation
For in vitro degradation tests, 20 mg of A-CHAM, B-CHAM, C-
CHAM and D-CHAM were, respectively, incubated in 10 mL
phosphate buﬀered saline (PBS) solution at the pH of 3, 5 and 7,44790 | RSC Adv., 2017, 7, 44788–44798and the medium were maintained in a 37 C shaker at 300 rpm
for one month. 2 mL of the supernatant was collected from the
mixture by centrifugation at designated time intervals, and the
withdrawn solution was replaced by the same volume of fresh
PBS at specic pH value. The degradation of CHAMs was
determined by measuring the released calcium ions in the
harvested supernatant with inductively coupled plasma atomic
emission spectroscopy (ICP-OES, Thermo, Waltham, MA, USA).
All the tests were repeated and carried out at least three times,
and the data are shown in mean values with standard
deviations.2.4. Drug entrapment eﬃciencies and releasing proles
1.5 mL cis-diammineplatinum(II) dichloride (CDDP, Sigma-
Aldrich, USA) solution at a concentration of 0.4 mg mL1 was
added to 20 mg of A-CHAM, B-CHAM, C-CHAM and D-CHAM,
respectively. A tube lled with 0.4 mg mL1 CDDP without
any sample was set as a control. Aer gentle vortexing, the
suspension was maintained in a shaker at 37 C at 300 rpm in
darkness. Aer 24 h, the CDDP loaded CHAMs were obtained by
centrifugation, rinsed with distilled water twice, and freezeThis journal is © The Royal Society of Chemistry 2017
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View Article Onlinedried overnight. The unloaded CDDP in the supernatant was
determined using ICP-OES, by measuring the concentration of
platinum. The CDDP entrapment eﬃciency was calculated
according to the formula: CDDP entrapment eﬃciency (%) ¼
(Ptcontrol Ptsupernatant)/Ptcontrol 100%, while the loaded CDDP
amount was calculated with the expression: CDDP loading
content (mg per 20 mg CHAM) ¼ (Ptcontrol  Ptsupernatant)  1.5.
In vitro drug releasing tests were done by adding PBS solu-
tion at the pH of 5 and 7 to the CDDP loaded CHAMs at a solid/
liquid ratio of 2 mg mL1, respectively. The mixture was
maintained in a shaker at 37 C at 300 rpm in darkness, 2 mL of
the medium was periodically extracted for the measurement of
platinum using ICP-OES, and the residual mixture was supple-
mented by 2 mL fresh PBS at the specic pH value. All the tests
were executed at least three times.2.5. Cytotoxicity assay
FaDu cells, a well-established human head and neck squamous
cell carcinoma cell line was received from American Type
Culture Collection (ATCC, VA, USA), and maintained in Dul-
becco's modied Eagle's medium (DMEM, Gibco, NY, USA)
supplemented with 10% (vol/vol) fetal bovine serum (Gibco,
USA) and 100 U mL1 penicillin–streptomycin (Gibco, USA) at
37 C in humidied atmosphere with 5% CO2. For studying the
cytotoxicity of the hollow microspheres, FaDu cells were seeded
in 96-well plate at a density of 5  103 cells per well. Aer 24 h
incubation, the culture medium was replaced by fresh DMEM
supplemented with A-CHAM, B-CHAM, C-CHAM or D-CHAM at
a series of concentrations (i.e. 0.5 mg mL1, 0.2 mg mL1,
0.1 mg mL1, and 0.01 mg mL1). The cell viability was tested
aer 48 h co-culture using MTT, 3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide assay. In brief, the culture
medium was replaced by 100 mL MTT solution and further
incubated for 4 h. Next, 100 mL SDS–HCl was added and mixed
thoroughly using the micropipette. The plate was maintained at
37 C in humidied chamber for 5 h to ensure complete
dissolution of formazan crystals. The absorbance was read at
the wavelength of 570 nm using a microplate spectrophotom-
eter (SpectraMax 340, Molecular Devices, CA, USA). The cyto-
toxicity of the CDDP loaded CHAMs were done by treating the
FaDu cells with DMEM supplemented with 0.1 mg mL1 CDDP
loaded A-CHAM, B-CHAM, C-CHAM or D-CHAM. The cell
survival rate was calculated by comparing the cell viability of the
studied group to that of control group. Each sample was per-
formed in triplicates.
The cellular attachment and engulfment of microspheres
were visualized by SEM (LEO 1530, Oberkochen, Germany) and
a confocal laser scanning microscope (CLSM, LSM700, Zeiss,
Jena, Germany). For SEM observation, FaDu cells incubated
with CDDP loaded and unloaded CHAMs for 48 h were thor-
oughly rinsed with PBS for three times, and then xed with
2.5% glutaraldehyde at 4 C overnight. The samples were
dehydrated with gradient alcohols and a vacuum freeze drier
(ES-2030, Hitachi, Kyoto, Japan). Then, the samples were coated
with the gold sputter (E1010, Hitachi ion sputter, Tokyo, Japan)
for 15 s before SEM observation at 5 kV. For CLSM observation,This journal is © The Royal Society of Chemistry 2017CHAMs were prestained by dispersing the microspheres in
0.05 mg mL1 rhodamine B isothiocyanate (RITC, Sigma-
Aldrich, USA) in PBS with vigorous stirring for 4 h. The RITC-
labeled CHAMs were harvested by centrifugation, and washed
with distilled water and ethanol, before being used for the
incubation with FaDu cells. Aer 48 h, the cells were washed
with PBS three times, xed by 4% paraformaldehyde and per-
meabilized with 0.2% Triton X-100. Then, the cytoskeleton and
nuclei of the FaDu cells were respectively stained with FITC-
phallotoxins (Sigma-Aldrich, USA) and Hoechst 33342 (Ther-
moFisher Scientic, USA).2.6. Statistical analysis
For drug entrapment eﬃciency and cell survival rate, data are
shown in mean values with standard deviations. One-way
analysis of variance (ANOVA) was performed with SPSS (v.13.0,
IBM SPSS, USA), and ‘P < 0.05’ was dened as the level of
signicant diﬀerence.3. Results and discussion
3.1. Sample preparation and characterization
The SEM and the attached TEM images (Fig. 2a–d) showed the
changes in the morphology of the CaCO3 precursors: with the
addition of SDS, the size of the microspheres increased from
around 2 mm in A-CHAM group, to more than 5 mm in D-CHAM
group. Additionally, the hollow space in the spheres was also
enlarged with the increase in SDS concentration. Specically, in
A-CHAM group, most of the microspheres remained solid
without obvious hollow inside. Whilst in D-CHAM group, due to
the expansion of the hollow space, the sphere wall became so
thin to become disconnected at specic site. Fig. 2e–h shows
the morphology of the fabricated CHAMs through hydro-
thermal reaction. It can be seen that the hollow space inside the
microspheres can be more clearly seen in group C and D, which
is similar to the situations observed in CaCO3 precursors.
However, with the growth in the size of hollow, the sphere walls
become thinner in D-CHAM (i.e. 0.8 mm), making the sphere
more fragile. Consequently, unlike the other groups, more
broken and collapsed microspheres, or even HAp debris can be
found in D-CHAMs. This is consistent with the previous nding
showing that, when the concentration of SDS exceed 20 mM,
more dispersed CaCO3 particles, instead of homogeneous
hollow microspheres were present.30
The high magnication TEM images and the corresponding
SAED patterns shown in Fig. 3a–d demonstrate the CHAMs to
be composed of nano-sized HAp crystals, dramatically diﬀerent
from the sheet-like crystals in their precursors. The morphology
of HAp crystals in microspheres was reported to have signicant
inuence on the adsorption of drugs and proteins. In the
current study, the magnied images reveal there exists some
changes in the crystals shape among the four groups of CHAMs:
there are more needle-like shaped crystals in A-CHAM and B-
CHAM, while more rod or polygon shaped crystals were
observed in C-CHAM and D-CHAM. This indicated that the
concentration of SDS can also aﬀects the nanostructure of theRSC Adv., 2017, 7, 44788–44798 | 44791
Fig. 2 SEM images with inserted TEM images for calcium carbonate precursors of A-CHAM (a), B-CHAM (b), C-CHAM (c) and D-CHAM (d); SEM
images with inserted TEM images showing the morphology of A-CHAM (e), B-CHAM (f), C-CHAM (g) and D-CHAM (h) (scale bar ¼ 1 mm).
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View Article Onlinefabricated HAp microspheres as other crystal modiers (e.g.,
inositol hexakisphosphate35 and cyclohexane-1,2,3,4,5,6-
hexacarboxylic acid36) did in the synthesis of hollow HAp
microspheres. Moreover, it is evident in Fig. 3e and d that the
well-crystalized and oriented HAp crystals in nanoscale arrange
to form a great number of micro-pore structures, 100 nm in
diameter on the surface of the microspheres, which should have
crucial roles in increasing the adsorption area and accessibility
of the hollow space in the microspheres.
The phase purity of the CHAMs was conrmed by XRD and
demonstrated in Fig. 4a. The XRD patterns of the four groups ofFig. 3 Magniﬁed TEM (scale bar¼ 100 nm) images with corresponding S
of A-CHAM (a), B-CHAM (b), C-CHAM (c) and D-CHAM (d). Magniﬁed S
crystals and mesoporous structures of A-CHAM (e), B-CHAM (f), C-CHA
44792 | RSC Adv., 2017, 7, 44788–44798CHAMs were found to be consistent with the stoichiometric
HAp reference (JCPDS card #09-0432), and peaks indicating
other phases were present. However, the relatively sharper
peaks in low SDS used groups suggested that with the addition
of SDS in sample preparation, the crystallinity of CHAMs was
intriguingly decreased. Moreover, as demonstrated in the
expanded patterns at 31.5–33.5 (2q) in Fig. 4b, unlike the other
peaks, the (2 1 1), (1 1 2) and (3 0 0) peaks gradually shied to
a higher diﬀraction angles. In addition, the FTIR spectra of
CHAMs were investigated and are shown in Fig. 4c. Character-
istic bands corresponding to phosphate at 1091 cm1 (n3),AED patterns (scale bar¼ 5 1/nm) showing the nano-sized HAp crystals
EM (scale bar ¼ 100 nm) images showing the morphology of the HAp
M (g) and D-CHAM (h).
This journal is © The Royal Society of Chemistry 2017
Fig. 4 XRD patterns (a), expanded X-ray reﬂections (b) and FTIR spectra (c) of four groups of CHAMs; representative EDX spectrum and EDX-
mapping images showing the elemental composition and distribution of the microspheres (d).
Table 1 Elemental composition of the CHAMs measured by EDX
Sample
Atomic percentage (wt%)
Ca P O C Na
A-CHAM 10.3  0.8 7.7  0.6 60.2  2.1 20.4  1.6 1.4  0.3
B-CHAM 10.6  1.8 7.1  1.2 56.7  5.8 19.9  1.3 1.4  0.2
C-CHAM 10.6  0.9 7.4  0.3 58.9  0.2 21.3  1.2 1.8  0.05
D-CHAM 11.3  0.9 7.8  0.5 60.0  4.7 19.5  3.8 1.5  0.3
Paper RSC Advances
O
pe
n 
A
cc
es
s A
rti
cl
e.
 P
ub
lis
he
d 
on
 1
9 
Se
pt
em
be
r 2
01
7.
 D
ow
nl
oa
de
d 
on
 1
3/
12
/2
01
7 
06
:4
0:
32
. 
 
Th
is 
ar
tic
le
 is
 li
ce
ns
ed
 u
nd
er
 a
 C
re
at
iv
e 
Co
m
m
on
s A
ttr
ib
ut
io
n-
N
on
Co
m
m
er
ci
al
 3
.0
 U
np
or
te
d 
Li
ce
nc
e.
View Article Online1030 cm1 (n1), 601 cm
1 (n4) and 564 cm
1 (n4), as well as
hydroxyl at 3576 cm1 and 634 cm1 were evident. In addition,
bands indicating the presence of carbonate were observed at
1461–1410 cm1 (n3) and 873 cm
1 (n2), suggesting the CHAMs
prepared in this study to be B-type carbonated HAp.37
The composition of the CHAMs was analyzed by EDX, with
the representative EDX spectra and the corresponding mapping
gures shown in Fig. 4d. The detailed elemental composition of
the four groups of CHAMs is listed in Table 1. It can be seen that
the major elements within the microspheres were calcium,
phosphorus, oxygen and carbon, while only a very little amount
of sodium (less than 2%) was detected. The distribution of
calcium, phosphate, oxygen and sodium in the hollow CHAMs
were further demonstrated to be evenly inside and outside of
the spheres (Fig. 4d), which, along with the XRD and FTIR
results, indicates the CaCO3 precursors to be fully transformed
into carbonated HAp via hydrothermal reaction. Nevertheless,
the increase in SDS usage barely resulted in a signicant
diﬀerence in the element composition among the four groupsThis journal is © The Royal Society of Chemistry 2017of CHAMs. The Ca/P ratio of the four groups of CHAMs was also
similarly at around 1.4 level, without any noticeable diﬀerence.
The appreciable existence of carbonate substitution in HAp
determined by FTIR was conrmed by EDX. Given this, it is
expected to play an important role in the pH-selective drug
release property of the CHAMs, because of its pH-dependent
dissolution behavior. It was found the carbonate containing
HAp released around 42% less doxorubicin hydrochlorideRSC Adv., 2017, 7, 44788–44798 | 44793
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View Article Online(DOX) at the physiological pH, while it maintained the same
release prole in acidic environment as its counterpart without
carbonate incorporation.38 That said, the presence of sodium in
CHAM, though little, could have dramatic eﬀects on the phys-
icochemical and biological properties of the said materials.
Firstly, the incorporation of sodium decreases the crystallinity
of HAp,39 resulting in increased drug entrapment eﬃciency and
more sustained drug release. Secondly, the sodium content was
reported to contribute to the biocompatibility and osteo-
conductivity of HAp,40which benet the potential use of CHAMs
as a bone graing materials. Recently, trace ions like strontium
has been reported to aﬀect the size, morphology, and surface
area of the microspheres, which crucially promote their
performance.27,41 Therefore, it is rational to propose the
discrepancy among four groups of CHAMsmight also be caused
by the sodium content in SDS.
The eﬀects of SDS on the size of the microspheres were
further conrmed by particle analyzer. Fig. 5a–d demonstrate
the particle size distribution of the four groups of CHAMs. In A-
CHAM, more than 90% of the microspheres are under 3 mm in
diameter, while in B-CHAM group, more particles around 3 mm
in diameter or even larger were detected. When the concentra-
tion of SDS reached the CMC in C group, the particle size
increased to around 3–5 mm in diameter. However, in D-CHAM,
where SDS concentration exceeded CMC, the narrow distribu-
tion of microsphere seen in the other groups disappeared.
Instead, two sub-groups with the diameter of 0.6 and 5 mmwere
observed, respectively. This can be explained by the coexistence
of intact microspheres and the fragments due to the breakage of
the microspheres in D group, as observed in SEM. These results
were similar to the earlier investigation showing that, when
with PVP, high level of SDS could actually contribute to
dispersed particles, instead of evenly distributed hollow CaCO3Fig. 5 Particle size distribution of A-CHAM (a), B-CHAM (b), C-CHAM (c
bution of CHAMs measured by N2 adsorption (e). Cumulative calcium
and 7 (f).
44794 | RSC Adv., 2017, 7, 44788–44798microspheres.30 Collectively, it can be concluded the concen-
tration of SDS extensively used in the earlier publication6,12,26
(i.e., 0.1 M) is actually not the optimal choice for the preparation
of hollow HAp microspheres.3.2. Biodegradability
The N2 adsorption–desorption isotherm of the four groups of
CHAMs, as demonstrated in Fig. 5e, all exhibit the type H3/4
hysteresis loop, indicating the samples to be mesoporous
structures composed with nanocrystals with slit-shaped and
panel-shaped pores.42 The pore size distribution of CHAMs
measured from the adsorption branches of the isotherms using
the Barrett–Joyner–Halenda (BJH) method (Fig. 5e insets)
suggests the pore structures in the microspheres range from
3 nm to more than 100 nm, which is consistent with the
magnied SEM gures shown previously. However, the addition
of SDS seems to contribute to more pores in 20–100 nm range,
which might be related to more brittle sphere wall in high SDS
used group. Moreover, the Brunauer–Emmett–Teller (BET)
surface areas of the microspheres increased from 17.58 m2 g1
in A-CHAM to 25.12 m2 g1 in D-CHAM.
The degradation of as-prepared CHAMs was evaluated by
measuring the released calcium ions into the PBS at diﬀerent
pH values. The results shown in Fig. 5f indicate that the
degradation speeds of CHAMs are greatly inuenced by the
environmental pH value. In the initial 6 h, the CHAMs degraded
much more quickly in acidic condition than in neutral condi-
tion. This can be caused by the fast dissolution of the less
crystalized content, such as the incorporated carbonate. Aer
the rst day, the degradation rate in both acid and neutral
condition slowed down, and the gradual dissolution of calcium
was evident for up to 30 days. Moreover, we also noticed that the) and D-CHAM (d). Desorption isotherm and inserted pore size distri-
release showing the in vitro degradation of CHAMs in PBS at pH 3, 5
This journal is © The Royal Society of Chemistry 2017
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View Article Onlinedegradation behavior varies among the four groups of CHAMs.
For instance, at pH 3 and pH 7, D-CHAM degraded faster than
the other groups at rst stage. This can be explained by the
presence of small fragments from the burst microsphere, which
dissolves more quickly than the intact microspheres. In addi-
tion, it can be seen that the degradation rate of B-CHAM
remains to be the highest in the period of 30 day observation.
We propose the slower degradation of A-CHAM can be
explained by the increase in its crystallinity, while for C-CHAM,
the reason can be the increased particle size and the subsequent
decrease in the surface area.3.3. Drug loading and releasing
The increase in the size of microsphere, the hollow space, and
the surface area were found to have direct inuence on the drug
entrapment eﬃciency and releasing prole. Given this, CDDP,
a widely-used chemotherapy drug showing a high level and
broad spectrum of antitumor activity,43 was chosen as a model
drug. It was previously reported that the adsorption of CDDP
happens aer its hydrolysis in solution, resulting in the absence
of chlorine.44,45 Thus, the concentration of Pt in the solution was
measured for investigating the drug entrapment eﬃciency and
releasing prole of CDDP. The CDDP entrapment eﬃciency
shown in Fig. 6a reveals that C-CHAM can carry signicant more
(P < 0.05) amount of CDDP than any other groups. This may be
due to the decreased crystallinity of C-CHAM when compared
with A-CHAM and B-CHAM, as more crystalized apatite was
known to be compromised for loading suﬃcient amounts of
CDDP.46 Moreover, the increased sphere size and hollow space
might also contribute to the increase in loading capacity.
Nevertheless, D-CHAM, which seems to bear an even larger size
and hollow space, failed to favor drug loading as expected. It is
possible that the collapsed or broken microspheres in D groupFig. 6 CDDP entrapment eﬃciency of the four groups of CHAMs at 24 h
release in PBS at pH 5 (b) and pH 7 (c). Cell viability of FaDu cells cultured
of CDDP loaded CHAMs to FaDu cells at 24 h and 72 h (e); asterisks den
This journal is © The Royal Society of Chemistry 2017can barely carry the drug as eﬀective as the well-structured
microsphere in C group did.
Since the HAp crystal bounded CDDP was previously re-
ported to be very stable, and its release in PBS at pH 7.4 can last
for a long period of time.44 In the current study, the four groups
of CDDP loaded CHAMs were respectively immersed in PBS at
diﬀerent pH values, and a total of 30 days were allowed for
a clear understanding on the kinetics of drug release. As shown
in Fig. 6b and c, the release of CDDP was determined by the
cumulative Pt amount in the solution. For all the tested
samples, the drug release prole clearly presents a two-stage
manner: the quick release in the rst 12 h followed by
a period of slow and steady release. We propose that the initial
bust release of Pt could be caused by the surface bound CDDP,
while the later sustained release could originate from the inner
encapsulated CDDP. This also explains why the slow release
stage is more prominent in C-CHAM and D-CHAM, where
hollow space within the microsphere is assured. The lasting
release of CDDP aer the rst 24 h, as well as the delayed
cytotoxicity of the CHAMs on day three (Fig. 6e) suggest the
initial burst release of drug from microspheres was avoided. In
addition, by comparing the releasing curve in Fig. 6b and c, it
can be concluded that CDDP loaded on CHAMs released much
faster in acidic condition, which is commonly found in the
tumor microenvironment.47 The pH-dependent release prole
could be explained by the distinct degradation of CHAMs in
diﬀerent pH environment, because the carbonate content in
CHAMs are very sensitive to the change in the local pH value.
Moreover, it is evident that the cumulative amount of released
Pt from the four groups of CHAMs are proportional to the
entrapment eﬃciency of the samples: C-CHAM > D-CHAM $ B-
CHAM > A-CHAM. Collectively, C-CHAMmight be considered as
the optimal microsphere for the carrying and controlled release
of CDDP.(a); CDDP release proﬁle of CHAMs measured by cumulative platinum
with diﬀerent concentrations of unloaded CHAMs (d). Cell cytotoxicity
ote a signiﬁcant diﬀerence (according to ANOVA): *p < 0.05.
RSC Adv., 2017, 7, 44788–44798 | 44795
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View Article Online3.4. Cytotoxicity and cellular response
The cytotoxicity of the unloaded and CDDP loaded CHAMs was
done using an MTT assay on the FaDu cell line, a human head
and neck squamous cell carcinoma cell line that sensitively
responds to CDDP. Fig. 6d revealed that no cytotoxicity could be
detected when the concentration of unloaded CHAMs was
under 0.1 mg mL1, while when the solid/liquid ratio exceed
0.2 mg mL1, the cytotoxicity became detectable, especially in
D-CHAM, where the highest concentration of SDS was used. The
cell viability of FaDu cells co-cultured with 0.5 mg mL1
microspheres dropped down to 75% in A-CHAM group and
under 50% in D-CHAM group. Since with the increase in SDS
usage, the residual SDS could become more diﬃcult to elimi-
nate, thus, our data provides a good reason to minimize the
addition of SDS in sample preparation. In addition, the cell
survival rate of FaDu cells treated with CDDP loaded CHAMs for
24 h or 72 h were shown in Fig. 6e, indicating C-CHAM to be the
most eﬀective group to kill the FaDu cells on both day one and
three. This eﬀect was more prominent on day three with the cell
survival rate in group C to drop to only20%, nearly half of that
in group A and B, which is consistent to the drug entrapment
eﬃciency results indicating C-CHAM to be the most eﬀective
carrier for CDDP. However, there seems to be no signicant
diﬀerence between C-CHAM and D-CHAM in terms of their
cytotoxicity to the FaDu cell on either time point.
The cellular response of FaDu cells to CHAMs was observed
using SEM (Fig. 7a–d) and CLSM (Fig. 7e and f) respectively.
Both the CDDP loaded and unloaded CHAMs could spontane-
ously attached to the seeded FaDu cells, but act on the cells in
diﬀerent ways. Aer the treatment of CDDP loaded CHAMs, the
FaDu cells lost their cobblestone-like morphology and appearedFig. 7 SEM images (scale bar ¼ 10 mm) showing the cell morphology of F
(c); the cell surface areas with the attached CHAMs in orange boxes were
(b), unloaded CHAM (d); confocal microscopic image (scale bar¼ 10 mm)
stained with nucleus (blue) and cytoskeleton (green) (e); cross-sectional v
44796 | RSC Adv., 2017, 7, 44788–44798in apoptosis-like morphology (Fig. 7a) characterized by cell
shrinkage, cell detachment, as well as condensation and
rounding of the cytoplasm.48 The unloaded CHAMs didn't lead
to a prominent change in the morphology of the FaDu cells
(Fig. 7c), but, instead, the invagination of cell membrane
around the microsphere was evident (Fig. 7d), implying the
particles were being pulled into the cell. To further prove the
cell engulfment of the CHAMs, the microspheres were conju-
gated with RITC via the amine group on their surface. As shown
in Fig. 7e, the attachment of RITC labeled CHAMs (red) to the
FaDu cells stained with the nucleus (blue) and the cytoskeleton
(green) could be clearly visualized under CLSM. The orthogonal
views confocal images in Fig. 7f clearly demonstrated that one
microsphere located intracellularly.
Cancer cells are expected to carry negative surface charge
due to their abnormal secretion of lactate across plasma
membranes, which is rarely seen in normal cells.49 On the other
hand, although HAp is normally neutral in surface charge,
a small positive charge can be acquired through unequal
adsorption of oppositely charged ions, which is quite common
in physiological condition.50 In the current study, all four
groups of CHAMs were determined to carry a positive zeta
potential in 1 mM KCl solution. This positive surface charge
makes HAp based microspheres a potential candidate for the
delivery of cancer targeting drugs. Moreover, the biocompati-
bility and biodegradability of the CHAMs, as shown above, allow
them to be recognized and engulfed by cells, suggesting there
remains various applications to be discovered. For example, in
some recent studies, hollow HAp microspheres were graed
with aliphatic poly(urethane-amine) to obtain thermal respon-
sive drug release,51 or incorporated with Fe3O4 to gain magneticaDu cells treated with CDDP loaded CHAMs (a), and unloaded CHAMs
further shown in magniﬁcation (scale bar¼ 1 mm): CDDP loaded CHAM
showing the RITC labeledmicrospheres (red) attached to the FaDu cells
iew and lateral views showing amicrosphere engulfed by a FaDu cell (f).
This journal is © The Royal Society of Chemistry 2017
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View Article Onlineproperties.6 They could also be encapsulated in sodium algi-
nate52 or collagenmatrix53 to increase their clinical performance
and workability.
4. Conclusion
Hollow CaCO3 precursors were prepared via fast precipitation
using SDS at a much lower concentration than reported previ-
ously, and the precursors can be directly transformed into
hollow mesoporous microspheres composed of nano-sized
carbonated hydroxyapatite crystals through hydrothermal
reaction. The hollow mesoporous CHAMs exhibit excellent
biodegradability and sustained drug release properties in a pH-
dependent manner, due to the distinct dissolution behavior of
the sphere wall under acidic and neutral environment. The
positively charged CHAMs can be loaded with CDDP to induce
apoptosis of cancer cells through either direct attachment or
engulfment. In addition, it was demonstrated that the particle
size, hollow structure and wall thickness of the microspheres
can be well controlled by simply adjusting the concentration of
SDS in the reaction. The optimal morphology of CHAM was
demonstrated to be achieved when using SDS at its CMC,
indicated by it the highest entrapment eﬃciency of CDDP and
the strongest killing eﬀects on human squamous cell carcinoma
cells.
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